Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int Wound J ; 21(4): e14621, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38531355

RESUMEN

Hyperbaric oxygen therapy (HBOT) has been used in patients with diabetic foot ulcers (DFU) for many years, but its clinical efficacy is still controversial. Therefore, this study explored the efficacy of HBOT applied to DFU by means of meta-analysis. PubMed, Cochrane Library, Embase, CNKI and Wanfang databases were searched, from database inception to October 2023, and published randomised controlled trials (RCTs) of HBOT in DFU were collected. Two investigators independently screened the collected literature, extracted relevant data and assessed the quality of the literature. Review Manager 5.4 software was applied for data analysis. Twenty-nine RCTs with 1764 patients were included. According to the combined results, when compared with conventional treatment, HBOT significantly increased the complete healing rate of DFUs (46.76% vs. 24.46%, odds ratio [OR]: 2.83, 95% CI: 2.29-3.51, p < 0.00001) and decreased the amputation rate (26.03% vs. 45.00%, OR: 0.41, 95% CI: 0.18-0.95, p = 0.04), but the incidence of adverse events was significantly higher in patients (17.37% vs. 8.27%, OR: 2.49, 95% CI: 1.35-4.57, p = 0.003), whereas there was no significant difference in the mortality (6.96% vs. 12.71%, OR: 0.52, 95% CI: 0.21-1.28, p = 0.16). Our results suggest that HBOT is effective in increasing the complete healing rate and decreasing the amputation rate in patients with DFUs, but increases the incidence of adverse events, while it has no significant effect on mortality.


Asunto(s)
Pie Diabético , Oxigenoterapia Hiperbárica , Cicatrización de Heridas , Humanos , Pie Diabético/terapia , Oxigenoterapia Hiperbárica/métodos , Ensayos Clínicos Controlados Aleatorios como Asunto , Resultado del Tratamiento
2.
Support Care Cancer ; 32(2): 98, 2024 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-38200265

RESUMEN

PURPOSE: Breast cancer survivors face dual challenges: long-term sequelae of treatment and the risk of recurrent disease. Furthermore, obesity and a sedentary lifestyle can complicate both challenges. We aimed to assess the effect of a 12-week exercise-based weight-management program in overweight/obese breast cancer survivors. METHODS: A two-arm, single-blinded, randomized controlled trial was conducted among 60 overweight/obese, stage 0-III breast cancer survivors. During the 12-week program, the intervention group received weekly information support, fortnightly exercise prescriptions, including aerobic and resistance exercises to perform at home, and one dietary instruction. The control group received information support about weight management and exercise. Weight, body composition, and physical fitness data were collected at baseline, postintervention, and the 3-month follow-up. RESULTS: The intervention group showed significant improvements in body weight and all adiposity indices, including body mass index, waist circumference, and %body fat, in comparison with baseline (P < 0.001) and the control group (P < 0.05). Both groups showed no significant changes in fat-free mass during the 6-month period (P > 0.05). International Physical Activity Questionnaire scores and left grip strength increased significantly in the intervention group in comparison with the baseline (P < 0.01) and the control group (P < 0.05). Right grip strength, lower-body strength, and aerobic endurance showed no significant intergroup differences (P > 0.05). CONCLUSIONS: A combination of exercise prescription and weight-loss interventions yielded clinically meaningful weight loss in overweight/obese breast cancer survivors. These findings may facilitate the incorporation of home-based exercise and weight management into breast cancer treatment and survivorship care.


Asunto(s)
Carcinoma de Mama in situ , Neoplasias de la Mama , Supervivientes de Cáncer , Humanos , Femenino , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/terapia , Sobrepeso/terapia , Mama , Obesidad/terapia
4.
Nat Commun ; 10(1): 1507, 2019 04 03.
Artículo en Inglés | MEDLINE | ID: mdl-30944315

RESUMEN

Exhaustion of cytotoxic effector natural killer (NK) and CD8+ T cells have important functions in the establishment of persistent viral infections, but how exhaustion is induced during chronic hepatitis C virus (HCV) infection remains poorly defined. Here we show, using the humanized C/OTg mice permissive for persistent HCV infection, that NK and CD8+ T cells become sequentially exhausted shortly after their transient hepatic infiltration and activation in acute HCV infection. HCV infection upregulates Qa-1 expression in hepatocytes, which ligates NKG2A to induce NK cell exhaustion. Antibodies targeting NKG2A or Qa-1 prevents NK exhaustion and promotes NK-dependent HCV clearance. Moreover, reactivated NK cells provide sufficient IFN-γ that helps rejuvenate polyclonal HCV CD8+ T cell response and clearance of HCV. Our data thus show that NKG2A serves as a critical checkpoint for HCV-induced NK exhaustion, and that NKG2A blockade sequentially boosts interdependent NK and CD8+ T cell functions to prevent persistent HCV infection.


Asunto(s)
Hepacivirus/inmunología , Hepatitis C Crónica/inmunología , Células Asesinas Naturales/inmunología , Subfamília C de Receptores Similares a Lectina de Células NK/inmunología , Animales , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Citocinas/inmunología , Modelos Animales de Enfermedad , Hepatitis C Crónica/virología , Hepatocitos/virología , Antígenos de Histocompatibilidad Clase I/inmunología , Interferón gamma/inmunología , Activación de Linfocitos/fisiología , Proteínas de la Membrana/inmunología , Ratones , Distribución Aleatoria
5.
Invest New Drugs ; 37(6): 1177-1186, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-30847721

RESUMEN

The dyskeratosis congenita 1 (DKC1) gene is located on the X chromosome at Xq28. Dyskerin encoded by the DKC1 gene is associated with the formation of certain small RNAs and the telomerase activity. Inherited mutations in DKC1 inactivate the dyskerin and causes dyskeratosis congenital, which is characterized by skin defects, hematopoiesis failure, and increased susceptibility to cancer. DKC1 reportedly up-regulates in several human cancers, including renal cell carcinoma and prostate cancer. Dyskerin is deregulated in B-chronic lymphocytic leukemia and breast carcinomas, but its expression and function in glioma have hardly been investigated. Hence, we were prompted to collect tissue samples and implement cell experiments. Our study reveals that DKC1 expression is significantly increased in the pathological tissues of glioma compared with that in normal tissues. The increased staining of DKC1 is related to the World Health Organization stages of tumors. DKC1 knockdown also significantly inhibits glioma cell growth by altering the expression of cell cycle-relative molecules to arrest at the G1 phase. In the transwell chamber, DKC1 knockdown glioma cells exhibit low motility. Consistent with classic oncogenic pathways, N-cadherin, HIF-1α, and MMP2 expression levels are lower compared with those of the control group. Therefore, DKC1 up-regulation in gliomas is common and necessary for extensive tumor growth. The phenotype of glioma cell lines after DKC1 down-regulation suggests its use as a valuable clinical treatment strategy.


Asunto(s)
Neoplasias Encefálicas , Proteínas de Ciclo Celular , Glioma , Proteínas Nucleares , Adulto , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/mortalidad , Neoplasias Encefálicas/patología , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Línea Celular Tumoral , Movimiento Celular , Proliferación Celular , Femenino , Glioma/genética , Glioma/metabolismo , Glioma/mortalidad , Glioma/patología , Humanos , Estimación de Kaplan-Meier , Masculino , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo
6.
Oncotarget ; 6(25): 21406-20, 2015 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-26033551

RESUMEN

PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) is a novel cloned gene which has been identified as a major haploinsufficient tumor suppressor essential for maintaining telomerase activity, the length of telomerase and chromosome stability. This study explored the clinical significance and biological function of PinX1 in human clear cell renal cell carcinoma (ccRCC). The clinical relevance of PinX1 in ccRCC was evaluated using tissue microarray and immunohistochemical staining in two independent human ccRCC cohorts. Our data demonstrated that PinX1 expression was dramatically decreased in ccRCC tissues compared with normal renal tissues and paired adjacent non-tumor tissues. Low PinX1 expression was significantly correlated with depth of invasion, lymph node metastasis and advanced TNM stage in patients, as well as with worse overall and disease-specific survival. Cox regression analysis revealed that PinX1 expression was an independent prognostic factor for ccRCC patients. Moreover, PinX1 inhibited the migration and invasion of ccRCC by suppressing MMP-2 expression and activity via NF-κB-dependent transcription in vitro. In vivo studies confirmed that PinX1 negatively regulated ccRCC metastasis and the expression of MMP-2 and NF-κB-p65. These findings indicate that PinX1 suppresses ccRCC metastasis and may serve as a ccRCC candidate clinical prognostic marker and a potential therapeutic target.


Asunto(s)
Carcinoma de Células Renales/diagnóstico , Regulación Neoplásica de la Expresión Génica , Neoplasias Hepáticas/diagnóstico , Metaloproteinasa 2 de la Matriz/metabolismo , Factor de Transcripción ReIA/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Anciano , Animales , Carcinoma de Células Renales/metabolismo , Proteínas de Ciclo Celular , Línea Celular Tumoral , Movimiento Celular , Estudios de Cohortes , Citoplasma/metabolismo , Supervivencia sin Enfermedad , Femenino , Perfilación de la Expresión Génica , Humanos , Inmunohistoquímica , Neoplasias Hepáticas/metabolismo , Masculino , Inhibidores de la Metaloproteinasa de la Matriz/química , Ratones , Ratones Endogámicos BALB C , Persona de Mediana Edad , Invasividad Neoplásica , Metástasis de la Neoplasia , Análisis de Secuencia por Matrices de Oligonucleótidos , Pronóstico , Modelos de Riesgos Proporcionales , ARN Interferente Pequeño/metabolismo , Transducción de Señal
7.
Sci Rep ; 5: 9774, 2015 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-26021863

RESUMEN

CHIP (c-terminal Hsp70-interacting protein) is an E3 ligase which may play different roles in different cancers. The elucidation of the VHL-HIF-1α (hypoxia inducible factor-1α)-VEGF (vascular endothelial growth factor) pathway has led to the development of targeted therapy in renal cell carcinoma (RCC). However, little is known about the role of CHIP and the relationship between CHIP and VEGF-VEGFR2 (VEGF receptor 2) pathway in RCC. In this study, we found that the expression of CHIP was downregulated and significantly correlated with pT status (P = 0.022) and TNM stage (P = 0.022) in 304 RCC and 35 normal renal tissues using tissue microarray. Moreover, low expression of CHIP is a strong and independent negative prognostic value for RCC. In vitro, CHIP negatively regulated RCC cell migration, invasion and angiogenesis. In addition, ELISA tests showed that restoration of CHIP inhibited, while knockdown promoted, the secreted level of VEGF. Furthermore, western blot indicated that the VEGFR2 protein level was reduced after CHIP overexpression. Our findings demonstrate for the first time that CHIP may be involved in RCC angiogenesis through regulating VEGF secretion and expression of VEGFR2. CHIP may serve as promising prognostic biomarker of angiogenesis and may constitute a potential therapeutic target in RCC.


Asunto(s)
Carcinoma de Células Renales/genética , Neovascularización Patológica/genética , Ubiquitina-Proteína Ligasas/biosíntesis , Factor A de Crecimiento Endotelial Vascular/genética , Receptor 2 de Factores de Crecimiento Endotelial Vascular/genética , Anciano , Carcinoma de Células Renales/patología , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Transducción de Señal , Ubiquitina-Proteína Ligasas/genética , Factor A de Crecimiento Endotelial Vascular/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo
8.
Guang Pu Xue Yu Guang Pu Fen Xi ; 29(2): 519-21, 2009 Feb.
Artículo en Chino | MEDLINE | ID: mdl-19445242

RESUMEN

A study was carried out on the contents of six trace elements, Ca, Cu, Fe, Mn, Zn and K, in roots, stems, leaves, flowers and seeds of planted Scutellaria baicalensis, by flame atomic absorption spectrophotometry (FAAS). The results indicated that Scutellaria baicalensis was rich in trace elements, meaning that it has a relatively high nutritive value. In stems of Scutellaria baicalensis, the content sequence of the six trace elements was found to be Fe > Mn > Zn = Cu > K > Ca. In leaves, the content sequence of the six trace elements was Fe> Mn > Zn > Cu > K > Ca. In flowers and seeds it was Ca > Fe > Mn > Zn > Cu > K, and Ca > Fe > Zn > Mn > Cu >K, separately, and in roots it was Ca > Fe > Cu > Mn > Zn > K. The stems, leaves, flowers and seeds are rich in Fe, whose content is higher than that in pork liver, Mn and Zn, but lower in Ca. The flowers, seeds and roots are especially rich in Ca, whose content is higher than that in bone, indicating that different parts of Scutellaria baicalensis may accumulate different mineral element. This study, for the first time, researched into Ca, Cu, Fe, Mn, Zn and K contents in different parts of Scutellaria baicalensis, which helps explain the multifunction of Scutellaria baicalensis and provides theoretical basis for further developing its medical and edible value.


Asunto(s)
Minerales/análisis , Estructuras de las Plantas/química , Scutellaria baicalensis/química , Espectrofotometría Atómica , Flores/química , Hojas de la Planta/química , Raíces de Plantas/química , Tallos de la Planta/química , Scutellaria baicalensis/crecimiento & desarrollo , Semillas/química
9.
Guang Pu Xue Yu Guang Pu Fen Xi ; 29(1): 211-3, 2009 Jan.
Artículo en Chino | MEDLINE | ID: mdl-19385241

RESUMEN

Scutellaria baicalensis is one of the most important Chinese herbs. It is widely used in Asian medicine to improve impaired brain function and to treat headaches, and used to treat prostate cancer. It is also known to be anti-inflammatory and antifungal, and also seems to have antiviral properties, including possible effectiveness against HIV. Scutellaria baicalensis tea and other products are in development. In the present study, the content of selenium (Se) in leaves of planted and wild Scutellaria baicalensis was determined by fluorescence photometer. The contents of 18 kinds of amino acids in the leaves of planted and wild Scutellaria baicalensis were determined with amino acids instruments. The results showed that the two kinds of leaves were rich in Se content, and the content of Se in planted Scutellaria baicalensis (0.051 microg x g(-1)) was not significantly different from that in wild one (0.051 microg x g(-1), alpha = 0.05). The amino acids, of which the total content was up to 14.62% and 10.25% separately, were rich in both planted and wild Scutellaria baicalensis. Among the 18 kinds of amino acids, aspartic acid, glutamic acid and leucine were comparatively high in leaves of planted and wild Scutellaria baicalensis. There are 8 kinds of amino acids essential to human body, which were higher in leaves of planted Scutellaria baicalensis than those of wild one. This study, for the first time, determined Se and amino acids content in Scutellaria baicalensis and concluded that the leaves of planted type have Se and amino acids content not lower or higher than that of wild type, and the planted type could be a good substitute of wild type in the development of Scutellaria baicalensis products. This study also provided useful data for explaining the multifunction of Scutellaria baicalensis and theological basis for developing its medical and edible value.


Asunto(s)
Aminoácidos/análisis , Extractos Vegetales/química , Hojas de la Planta/química , Scutellaria baicalensis/química , Selenio/análisis , Aminoácidos/aislamiento & purificación , Aminoácidos/uso terapéutico , Humanos , Masculino , Fitoterapia , Tallos de la Planta , Neoplasias de la Próstata/tratamiento farmacológico , Selenio/aislamiento & purificación , Selenio/uso terapéutico , Té/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...